These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 26018859)

  • 21. HIV biological variability unveiled: frequent isolations and chimeric receptors reveal unprecedented variation of coreceptor use.
    Karlsson I; Antonsson L; Shi Y; Karlsson A; Albert J; Leitner T; Olde B; Owman C; Fenyö EM
    AIDS; 2003 Dec; 17(18):2561-9. PubMed ID: 14685050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prognostic value of the Na⁺/ H⁺ exchanger regulatory factor 1 (NHERF1) protein in cancer.
    Saponaro C; Malfettone A; Dell'Endice TS; Brunetti AE; Achimas-Cadariu P; Paradiso A; Mangia A
    Cancer Biomark; 2014; 14(2-3):177-84. PubMed ID: 24878819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulatory roles of NHERF1 and NHERF2 in cell surface expression of the glutamate transporter GLAST.
    Sato K; Otsu W; Otsuka Y; Inaba M
    Biochem Biophys Res Commun; 2013 Jan; 430(2):839-45. PubMed ID: 23200831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The efficiency of R5 HIV-1 infection is determined by CD4 T-cell surface CCR5 density through G alpha i-protein signalling.
    Lin YL; Mettling C; Portalès P; Réant B; Robert-Hebmann V; Reynes J; Clot J; Corbeau P
    AIDS; 2006 Jun; 20(10):1369-77. PubMed ID: 16791011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene expression profiling of luminal B breast cancers reveals NHERF1 as a new marker of endocrine resistance.
    Karn T; Ruckhäberle E; Hanker L; Müller V; Schmidt M; Solbach C; Gätje R; Gehrmann M; Holtrich U; Kaufmann M; Rody A
    Breast Cancer Res Treat; 2011 Nov; 130(2):409-20. PubMed ID: 21203899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A conditionally replicating HIV-based vector that stably expresses an antiviral shRNA against HIV-1 replication.
    Westerhout EM; Vink M; Haasnoot PC; Das AT; Berkhout B
    Mol Ther; 2006 Aug; 14(2):268-75. PubMed ID: 16697708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term inhibition of HIV-1 replication with RNA interference against cellular co-factors.
    Eekels JJ; Geerts D; Jeeninga RE; Berkhout B
    Antiviral Res; 2011 Jan; 89(1):43-53. PubMed ID: 21093490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complete knockdown of CCR5 by lentiviral vector-expressed siRNAs and protection of transgenic macrophages against HIV-1 infection.
    Anderson J; Akkina R
    Gene Ther; 2007 Sep; 14(17):1287-97. PubMed ID: 17597795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Construction of a lentiviral vector for RNA interference of PRL-3 gene and its stable expression in SW480 cells].
    Liu YH; Li JM; Zhou J; Ding YQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Apr; 28(4):509-12. PubMed ID: 18495578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of HIV-1 fusion with small interfering RNAs targeting the chemokine coreceptor CXCR4.
    Zhou N; Fang J; Mukhtar M; Acheampong E; Pomerantz RJ
    Gene Ther; 2004 Dec; 11(23):1703-12. PubMed ID: 15306840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. eIF4A2 is a host factor required for efficient HIV-1 replication.
    Ndzinu JK; Takeuchi H; Saito H; Yoshida T; Yamaoka S
    Microbes Infect; 2018; 20(6):346-352. PubMed ID: 29842983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting of
    Ma Q; Jiao Y; Hao Y; Yan S; Lyu N; Gao H; Li D; Liu Q; Zheng J; Song N
    Oncol Lett; 2016 Feb; 11(2):1149-1154. PubMed ID: 26893710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of caspase pathways limits CD4
    Holloway AJ; Saito TB; Naqvi KF; Huante MB; Fan X; Lisinicchia JG; Gelman BB; Endsley JJ; Endsley MA
    Retrovirology; 2024 May; 21(1):8. PubMed ID: 38693565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Na+/H+ exchanger regulatory factor-1 is involved in chemokine receptor homodimer CCR5 internalization and signal transduction but does not affect CXCR4 homodimer or CXCR4-CCR5 heterodimer.
    Hammad MM; Kuang YQ; Yan R; Allen H; Dupré DJ
    J Biol Chem; 2010 Nov; 285(45):34653-64. PubMed ID: 20801883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopamine receptor-interacting protein 78 acts as a molecular chaperone for CCR5 chemokine receptor signaling complex organization.
    Kuang YQ; Charette N; Frazer J; Holland PJ; Attwood KM; Dellaire G; Dupré DJ
    PLoS One; 2012; 7(7):e40522. PubMed ID: 22815758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppression of breast cancer cell growth by Na+/H+ exchanger regulatory factor 1 (NHERF1).
    Pan Y; Wang L; Dai JL
    Breast Cancer Res; 2006; 8(6):R63. PubMed ID: 17078868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Establishment of HIV-1 model cell line GHOST(3) with stable DRiP78 and NHERF1 knockdown.
    Zhang L; Huang XH; Zhou PP; Yu GL; Yan J; Qin B; Yan XG; Diao LM; Lin P; Kuang YQ
    Dongwuxue Yanjiu; 2015 May; 36(3):161-6. PubMed ID: 26018859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NHERF1 regulates gp120-induced internalization and signaling by CCR5, and HIV-1 production.
    Kuang YQ; Pang W; Zheng YT; Dupré DJ
    Eur J Immunol; 2012 Feb; 42(2):299-310. PubMed ID: 22028271
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.